Company Overview: Chek

Industry News

9 Mar

Check-Cap Reports Fourth Quarter and Fiscal Year 2016 Financial Results

ISFIYA, Israel, March 9, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the fourth quarter...

Read more

1 Mar

Check-Cap to Present at the 29th Annual ROTH Conference on March 14, 2017

ISFIYA, Israel, March 1, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer (CRC) screening, today announced that Bill Densel, Chief Executive Officer, will present at the 29th...

Read more

30 Jan

Check-Cap Ltd. to Webcast, Live, at VirtualInvestorConferences.com on Thursday, February 2

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com ISFIYA, Israel and BOSTON, Jan. 30, 2017 /PRNewswire/ — Check-Cap Ltd. (CHEK), engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening today announced that Bill Densel, CEO, will present live at VirtualInvestorConferences.com...

Read more

17 Jan

Check-Cap Enrolls First Patient in Clinical Trial to Support CE Mark of Its C-Scan® Colorectal Cancer Screening System

ISFIYA, Israel, January 17, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company developing a capsule-based system for preparation-free, colorectal cancer (CRC) screening, today announced the enrollment of the first patient in its multi-center study of the C-Scan® system in...

Read more

18 Oct

Check-Cap Announces Presentation of Clinical Data Demonstrating Safety and Detection of Polyps Using Preparation-Free Colorectal Cancer Screening Capsule

ISFIYA, Israel, Oct. 18, 2016 /PRNewswire/ — Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced additional clinical data on the Company’s minimally-invasive system was presented at the American College of Gastroenterology (ACG)...

Read more

13 Oct

Check-Cap Announces Upcoming Presentations Evaluating Preparation-Free Colorectal Cancer Screening Capsule

ISFIYA, Israel, Oct. 13, 2016 /PRNewswire/ — Check-Cap Ltd. (Nasdaq:  CHEK, CHEKW), a clinical stage medical diagnostics company, today announced upcoming presentations evaluating the Company’s ingestible capsule for preparation-free, colorectal cancer screening. Presentations will take place at the American College of Gastroenterology (ACG) Annual Scientific Meeting taking place October 14-19,...

Read more

7 Sep

Check-Cap to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016

ISFIYA, Israel, Sept. 7, 2016 /PRNewswire/ — Check-Cap Ltd. (Nasdaq:  CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that Bill Densel, Chief Executive Officer, will present at the Rodman & Renshaw 18th Annual Global Investment...

Read more

15 Aug

Check-Cap Reports Second Quarter 2016 Financial Results

ISFIYA, Israel, Aug. 15, 2016 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address